VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
MTDMettler-Toledo International Inc.
$1263.75$25.5B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksMTDFinancials

Mettler-Toledo International Inc. (MTD) Financials

29Y historyFree accessUpdated daily

Revenue growth remains cyclically inconsistent, fluctuating from a 11.6% contraction in 2023Q4 to 11.8% growth in 2024Q4, while operating margins remain constrained by high fixed costs, peaking at 31.9% in 2024Q4.

MTD Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97
Sales/Revenue4.09B4.03B3.87B3.79B3.92B3.72B3.09B3.01B2.94B2.73B2.51B2.4B2.49B2.38B2.34B2.31B1.97B1.73B1.97B1.79B1.59B1.48B1.4B1.3B1.21B1.15B1.1B1.07B935.7M878.4M
Revenue Growth %6.78%3.98%2.22%-3.35%5.43%20.51%2.54%2.49%7.73%8.64%4.71%-3.64%4.5%1.6%1.39%17.41%13.77%-12.39%10.01%12.47%7.58%5.56%7.67%7.47%5.72%4.79%2.82%13.87%6.52%-
Cost of Goods Sold1.73B1.71B1.62B1.62B1.68B1.61B1.34B1.32B1.3B1.19B1.12B1.06B1.16B1.12B1.12B1.11B945.82M851.36M990.82M909.25M815.98M763.59M734.3M686.25M645.97M619.14M578.5M560.1M495.6M467.9M
COGS % of Revenue-42.48%41.83%42.74%42.81%43.29%43.46%43.78%44.24%43.74%44.47%44.33%46.55%47.06%47.9%48.02%48.09%49.24%50.21%50.69%51.16%51.51%52.28%52.61%53.22%53.93%52.8%52.57%52.97%53.27%
Gross Profit2.36B2.32B2.25B2.17B2.24B2.11B1.74B1.69B1.64B1.53B1.39B1.33B1.33B1.26B1.22B1.2B1.02B877.49M982.53M884.5M778.93M718.88M670.15M618.18M567.74M528.88M517.05M505.4M440.1M410.5M
Gross Margin %57.79%57.52%58.17%57.26%57.19%56.71%56.54%56.22%55.76%56.26%55.53%55.67%53.45%52.94%52.1%51.98%51.91%50.76%49.79%49.31%48.84%48.49%47.72%47.39%46.78%46.07%47.2%47.43%47.03%46.73%
Gross Profit Growth %-2.82%3.86%-3.24%6.32%20.87%3.12%3.34%6.77%10.07%4.44%0.36%5.5%3.25%1.62%17.57%16.36%-10.69%11.08%13.55%8.35%7.27%8.41%8.88%7.35%2.29%2.31%14.84%7.21%-
Operating Expenses1.22B1.2B1.13B1.09B1.12B1.11B960.32M963.13M953.87M923.17M852.59M819.89M851.88M809.13M796.56M819.77M685.75M594.86M682.09M621.5M564.51M523.6M503M462.55M411.92M410.45M385.77M393.1M346.7M339.8M
OpEx % of Revenue-29.75%29.07%28.76%28.46%29.96%31.13%32.01%32.49%33.88%33.99%34.23%34.27%34.01%34.02%35.5%34.86%34.41%34.57%34.65%35.39%35.32%35.81%35.46%33.94%35.75%35.21%36.89%37.05%38.68%
Selling, General & Admin1.01B998.31M936.3M904.11M938.46M943.98M820.22M819.18M812.8M787.46M732.62M700.81M728.58M692.79M684.03M703.63M588.73M505.18M579.81M529.13M481.71M441.7M419.78M372.82M331.96M299.19M296.19M300.4M265.5M260.4M
SG&A % of Revenue-24.79%24.18%23.87%23.94%25.39%26.59%27.23%27.69%28.9%29.21%29.26%29.31%29.12%29.21%30.47%29.93%29.22%29.38%29.5%30.2%29.79%29.89%28.58%27.35%26.06%27.04%28.19%28.37%29.64%
Research & Development204.3M199.37M189.36M185.28M177.12M169.77M140.1M143.95M141.07M129.26M119.97M119.08M123.3M116.35M112.53M116.14M97.03M89.69M102.28M92.38M82.8M81.89M83.22M78M70.63M64.63M56.33M57.4M49M47.6M
R&D % of Revenue-4.95%4.89%4.89%4.52%4.57%4.54%4.78%4.81%4.74%4.78%4.97%4.96%4.89%4.81%5.03%4.93%5.19%5.18%5.15%5.19%5.52%5.93%5.98%5.82%5.63%5.14%5.39%5.24%5.42%
Other Operating Expenses00000000000000000000000384.55M341.29M46.63M33.25M35.3M32.2M31.8M
Operating Income1.15B1.12B1.13B1.08B1.13B994.74M784.04M728.39M682.98M609.91M540.19M513.68M476.86M450.37M423.34M380.69M335.34M282.63M300.44M263M214.42M195.29M167.15M155.63M155.82M118.43M131.28M112.3M93.4M70.7M
Operating Margin %28%27.78%29.11%28.5%28.73%26.76%25.41%24.21%23.27%22.38%21.54%21.44%19.18%18.93%18.08%16.49%17.05%16.35%15.22%14.66%13.44%13.17%11.9%11.93%12.84%10.32%11.98%10.54%9.98%8.05%
Operating Income Growth %--0.76%4.39%-4.13%13.22%26.87%7.64%6.65%11.98%12.91%5.16%7.72%5.88%6.38%11.2%13.53%18.65%-5.93%14.24%22.66%9.8%16.83%7.41%-0.12%31.57%-9.78%16.9%20.24%32.11%-
EBITDA1.24B1.24B1.25B1.2B1.24B1.1B882.75M817.07M767.67M686.04M608.98M577.72M539.66M509.67M478.12M430.19M379.87M324.11M339.98M301.34M251.99M232.7M206.08M192.44M190.54M155.41M164.53M147.6M125.6M102.5M
EBITDA Margin %30.35%30.9%32.29%31.7%31.62%29.66%28.61%27.16%26.15%25.18%24.28%24.12%21.71%21.42%20.42%18.63%19.31%18.75%17.23%16.8%15.8%15.7%14.67%14.75%15.7%13.54%15.02%13.85%13.42%11.67%
EBITDA Growth %1.76%-0.49%4.12%-3.1%12.37%24.93%8.04%6.43%11.9%12.65%5.41%7.05%5.88%6.6%11.14%13.25%17.2%-4.67%12.82%19.58%8.29%12.92%7.09%0.99%22.61%-5.55%11.47%17.52%22.54%-
D&A (Non-Cash Add-back)95.95M125.61M123.22M121.16M113.02M108.06M98.71M88.68M84.69M76.13M68.8M64.04M62.8M59.3M54.78M49.5M44.53M41.48M39.54M38.35M37.57M37.41M38.92M36.81M34.72M36.97M33.25M35.3M32.2M31.8M
EBIT1.14B1.11B1.1B1.06B1.13B991.83M787.25M723.3M685.83M608.69M531.18M493.64M466.42M422.34M402.37M369.4M326.59M249.2M291.46M263.87M222.34M175.06M167.11M155.63M155.82M118.43M131.28M112.27M93.36M70.7M
Net Interest Income-68.87M-68.52M-74.63M-77.37M-55.39M-43.24M-38.62M-37.41M-34.51M-32.78M-28.03M-27.45M-24.54M-22.71M-22.76M-23.23M-20.06M-25.12M-25.39M00000000000
Interest Income000000000000000000000000000000
Interest Expense68.87M68.52M74.63M77.37M55.39M43.24M38.62M37.41M34.51M32.78M28.03M27.45M24.54M22.71M22.76M23.23M20.06M25.12M25.39M00000000000
Other Income/Expense-88.54M-69.58M-89.83M-105.95M-55.63M-45.38M-35.3M-46.99M-31.12M-35.69M-36M-50.26M-31.85M-47.66M-40.74M-31.52M-27.82M-57.87M-34.37M-20.13M-9.57M-35.1M-12.93M-18.72M-45.41M0-22.65M-32.77M-34.76M-77.1M
Pretax Income1.06B1.05B1.04B973.73M1.07B949.36M748.74M681.39M651.86M574.22M504.19M463.42M445M402.71M382.6M349.18M307.51M224.76M266.07M242.87M2.05B160.18M154.22M136.91M110.41M118.43M108.63M79.5M58.6M-6.4M
Pretax Margin %25.84%26.05%26.79%25.7%27.31%25.53%24.27%22.65%22.21%21.07%20.1%19.35%17.9%16.93%16.34%15.12%15.63%13%13.48%13.54%128.44%10.81%10.98%10.5%9.1%10.32%9.92%7.46%6.26%-0.73%
Income Tax181.56M179.72M174.08M184.95M198.09M180.38M146M120.28M139.25M198.25M119.82M110.6M106.76M96.61M91.75M79.68M75.36M52.17M63.29M64.36M47.31M51.28M46.27M41.07M9.99M46.17M38.51M31.4M21M17.5M
Effective Tax Rate %17.18%17.13%16.78%18.99%18.5%19%19.5%17.65%21.36%34.52%23.77%23.87%23.99%23.99%23.98%22.82%24.51%23.21%23.79%26.5%2.31%32.01%30%30%9.05%38.98%35.45%39.5%35.84%-273.44%
Net Income875.06M869.19M863.14M788.78M872.5M768.99M602.74M561.11M512.61M375.97M384.37M352.82M338.24M306.09M290.85M269.49M232.15M172.59M202.78M178.51M157.53M108.9M107.96M95.84M100.42M72.26M70.12M48.1M37.6M-65.9M
Net Margin %21.4%21.59%22.29%20.82%22.26%20.68%19.54%18.65%17.46%13.8%15.32%14.73%13.61%12.87%12.42%11.67%11.8%9.98%10.28%9.95%9.88%7.35%7.69%7.35%8.27%6.29%6.4%4.51%4.02%-7.5%
Net Income Growth %3.04%0.7%9.43%-9.6%13.46%27.58%7.42%9.46%36.34%-2.18%8.94%4.31%10.5%5.24%7.92%16.09%34.51%-14.89%13.6%13.31%44.65%0.88%12.65%-4.56%38.96%3.06%45.78%27.93%157.06%-
Net Income (Continuing)875.06M869.19M863.14M788.78M872.5M768.99M602.74M561.11M512.61M375.97M384.37M352.82M338.24M306.09M290.85M269.49M232.15M172.59M202.78M178.51M157.53M108.9M107.96M95.84M100.42M72.26M70.12M48.1M37.6M-23.9M
Discontinued Operations000000000000000000000000000000
Minority Interest00000000000000000000000000004.2M3.5M
EPS (Diluted)43.1442.1740.6735.9038.4132.7824.9122.4719.8814.2414.2212.4811.449.969.148.216.805.035.794.703.862.522.372.112.211.681.661.160.92-2.08
EPS Growth %6.48%3.69%13.29%-6.53%17.18%31.59%10.86%13.03%39.61%0.14%13.94%9.09%14.86%8.97%11.33%20.74%35.19%-13.13%23.19%21.76%53.17%6.33%12.32%-4.52%31.55%1.2%43.1%26.09%144.23%-
EPS (Basic)-42.1740.6736.1038.7933.2525.2422.8420.3314.6214.4912.7511.7110.229.378.456.985.125.924.823.932.582.442.152.271.781.801.250.98-2.08
Diluted Shares Outstanding20.29M20.61M21.32M21.97M22.72M23.46M24.2M24.97M25.78M26.39M27.02M28.27M29.57M30.73M31.82M32.84M34.14M34.29M35.05M37.95M40.79M43.29M45.48M45.51M45.37M42.98M42.14M41.3M40.68M31.62M
Basic Shares Outstanding20.29M20.61M21.22M21.85M22.49M23.13M23.88M24.57M25.22M25.71M26.52M27.68M28.89M29.95M31.04M31.9M33.28M33.72M34.25M37.03M40.07M42.21M44.24M44.47M44.28M40.61M38.9M38.52M38.36M31.62M
Dividend Payout Ratio------------------------------

Key Metrics

Growth RegimeMixed
ProfitabilityStrong
Balance SheetStrained
Cash FlowStable
Top Statement Risk

China market demand volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Revenue Growth Exhibits Cyclical Inconsistency

According to the provided quarterly financial data, MTD's revenue growth has fluctuated significantly, ranging from a contraction of 11.6% in 2023Q4 to a peak growth of 11.8% in 2024Q4, suggesting that the company's top-line performance remains highly sensitive to broader industrial and laboratory capital expenditure cycles.

The inconsistent revenue trajectory indicates that MTD is struggling to maintain a steady organic growth cadence in the face of shifting global demand. Investors should monitor whether the recent 3.98% growth rate represents a stabilization or a precursor to further deceleration as end-market capital budgets tighten.

Resilient Gross Margins Defend Profitability

As reported in the income statement, MTD has maintained a robust gross margin profile consistently hovering near 57.5%, which underscores the company's significant pricing power and the premium value placed on its precision weighing instruments within highly regulated life science and manufacturing environments.

This structural margin stability suggests that MTD successfully mitigates input cost volatility through its specialized product mix. However, the lack of significant margin expansion despite these high levels may imply that the company has reached a ceiling in its ability to extract further pricing premiums.

Operating Leverage Constrained by Overhead

Based on the historical income statement figures, operating margins have fluctuated between 24.8% and 31.9%, indicating that MTD's operating leverage is not scaling linearly with gross profit, likely due to the high fixed costs associated with its global direct sales and technical service network.

The inability to consistently expand operating margins during periods of revenue growth suggests that the 'Stern Drive' productivity initiative may be offset by rising SG&A requirements. This warrants further investigation into whether the company's current cost structure is becoming too rigid to support future profitability gains.

Buybacks Masking Underlying Earnings Volatility

Financial statements reveal that MTD's EPS growth is frequently decoupled from net income performance, with the company utilizing aggressive share repurchases to artificially inflate per-share metrics, a strategy that appears to be a primary driver of shareholder value in the absence of consistent organic earnings expansion.

The reliance on share buybacks to drive EPS growth raises questions regarding the sustainability of the company's valuation multiples. Investors should be cautious, as this capital allocation strategy may be masking underlying operational weaknesses and a lack of reinvestment into higher-growth opportunities.

Structural Risks to Valuation Multiples

Analysis of the company's recent filings suggests that MTD's high valuation relative to peers may be unsustainable, given the combination of decelerating revenue growth, high geographic concentration in China, and a thin cash position that limits the company's flexibility to navigate potential economic downturns.

Short-sellers would likely focus on the potential for margin compression if the company's high-end laboratory segment faces a sustained slowdown in biopharma R&D spending. The current reliance on debt-funded buybacks in a high-rate environment could further exacerbate risks to the company's long-term financial health.

MTD — Frequently Asked Questions

Quick answers to the most common questions about buying MTD stock.

What was Mettler-Toledo International Inc.'s (MTD) revenue in 2025?

For fiscal year 2025, Mettler-Toledo International Inc. (MTD) reported total revenue of $4.03B. This represents a 358.4% increase compared to $878.4M in 1997.

Is Mettler-Toledo International Inc. (MTD) profitable?

Mettler-Toledo International Inc. (MTD) is profitable, generating $869.2M in net income for the fiscal year ending 2025 with a net profit margin of 21.6%.

What is Mettler-Toledo International Inc.'s operating profit margin?

Mettler-Toledo International Inc. (MTD) reported an operating income of $1.12B, resulting in an operating profit margin of 27.8%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Mettler-Toledo International Inc.'s gross profit and gross margin?

Mettler-Toledo International Inc. (MTD) generated $2.32B in gross profit for the year, representing a gross profit margin of 57.5%. This demonstrates the company's core pricing power and production efficiency.